NCT04022226View on ClinicalTrials.gov

EEG Characteristics in ECT

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Electroconvulsive TherapyDirect Current ElectroencephalogramKetamineSpreadind Depression
Interventions
DRUG

Ketamine

Induction agent that suppresses infra-slow waves

DRUG

Methohexital

Induction agent that does not suppress infra-slow waves

Trial Locations (1)

87106

University of New Mexico Mental Health Center, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT04022226 - EEG Characteristics in ECT | Biotech Hunter | Biotech Hunter